概括
在住院的COVID-19患者中,阿司匹林没有降低28天的死亡率. 然而,阿司匹林使用与活出院的患者数量略有增加和血栓事件的减少以及严重出血的增加有关.
科学领域:
- 临床医学
- 传染性疾病
- 药理学
背景情况:
- 阿司匹林的抗血栓性质表明它有可能作为一种COVID-19治疗方法.
- 该RECOVERY试验调查了阿司匹林在住院COVID-19患者中的有效性和安全性.
研究的目的:
- 评估阿司匹林在住院COVID-19患者中的有效性和安全性.
- 确定阿司匹林对28天死亡率和其他临床结果的影响.
主要方法:
- 一个随机,受控,开放的平台试验,涉及177家英国医院和其他国际医院的14892名符合条件的患者.
- 患者分为1:1接受阿司匹林 (每天150毫克) 或常规治疗.
- 主要结局是28天死亡率,根据治疗意向进行分析.
主要成果:
- 在阿司匹林和常规治疗组之间28天死亡率没有显著差异 (17%对17%;率比0. 96).
- 阿司匹林组的住院时间较短,28天内活出院的比率更高 (75% vs 74%).
- 阿司匹林使用减少了血栓事件,但增加了重大出血事件.
结论:
- 阿司匹林没有降低住院COVID-19患者的28天死亡率或机械通风/死亡风险.
- 阿司匹林与在28天内活出院的比例略有增加.
- 这项研究强调了阿司匹林减少血栓事件和增加出血风险之间的权衡.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
799
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
982
相关概念视频
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Controls in Experiments
13.1K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
13.1K
Randomized Experiments
6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.3K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
